ABT Abbott Laboratories
Price (delayed)
$134.92
Market cap
$234.01B
P/E Ratio
40.88
Dividend/share
$2.24
EPS
$3.3
Enterprise value
$241.43B
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott
Highlights
The EPS has grown by 12% YoY and by 3.8% from the previous quarter
Abbott Laboratories's net income has increased by 12% YoY and by 3.8% QoQ
ABT's P/E is 20% above its last 4 quarters average of 34.0 and 17% above its 5-year quarterly average of 34.8
ABT's quick ratio is down by 3.8% year-on-year
Key stats
What are the main financial stats of ABT
Market
Valuations
Earnings
Shares outstanding
1.73B
Market cap
$234.01B
Enterprise value
$241.43B
Price to earnings (P/E)
40.88
Price to book (P/B)
5.86
Price to sales (P/S)
5.69
EV/EBIT
32.8
EV/EBITDA
22.81
EV/Sales
5.86
Revenue
$41.22B
Gross profit
$22.9B
Operating income
$6.69B
Net income
$5.77B
EBIT
$7.36B
EBITDA
$10.58B
Free cash flow
$6.49B
Per share
Balance sheet
Liquidity
EPS
$3.3
EPS diluted
$3.29
Free cash flow per share
$3.73
Book value per share
$23.01
Revenue per share
$23.7
TBVPS
$24.92
Total assets
$74.36B
Total liabilities
$34.33B
Debt
$14.98B
Equity
$40.03B
Working capital
$8.9B
Debt to equity
0.37
Current ratio
1.6
Quick ratio
1
Net debt/EBITDA
0.7
Margins
Efficiency
Dividend
EBITDA margin
25.7%
Gross margin
55.6%
Net margin
14%
Operating margin
16.2%
Return on assets
7.9%
Return on equity
14.7%
Return on invested capital
20.8%
Return on capital employed
12.4%
Return on sales
17.9%
Dividend yield
1.66%
DPS
$2.24
Payout ratio
67.9%
ABT stock price
How has the Abbott Laboratories stock price performed over time
Intraday
1.31%
1 week
3.3%
1 month
15.52%
1 year
14.47%
YTD
19.28%
QTD
19.28%
Financial performance
How have Abbott Laboratories's revenue and profit performed over time
Revenue
$41.22B
Gross profit
$22.9B
Operating income
$6.69B
Net income
$5.77B
Gross margin
55.6%
Net margin
14%
The operating income has grown by 12% YoY and by 3.3% from the previous quarter
Abbott Laboratories's net income has increased by 12% YoY and by 3.8% QoQ
Abbott Laboratories's net margin has increased by 9% YoY and by 2.9% QoQ
Abbott Laboratories's operating margin has increased by 8% YoY
Growth
What is Abbott Laboratories's growth rate over time
Valuation
What is Abbott Laboratories stock price valuation
P/E
40.88
P/B
5.86
P/S
5.69
EV/EBIT
32.8
EV/EBITDA
22.81
EV/Sales
5.86
ABT's P/E is 20% above its last 4 quarters average of 34.0 and 17% above its 5-year quarterly average of 34.8
The EPS has grown by 12% YoY and by 3.8% from the previous quarter
ABT's price to book (P/B) is 20% higher than its last 4 quarters average of 4.9 and 9% higher than its 5-year quarterly average of 5.4
ABT's equity is up by 6% year-on-year
ABT's P/S is 21% above its last 4 quarters average of 4.7 and 19% above its 5-year quarterly average of 4.8
The revenue has grown by 3.1% YoY
Efficiency
How efficient is Abbott Laboratories business performance
Abbott Laboratories's return on assets has increased by 13% YoY and by 3.9% QoQ
ABT's ROE is up by 7% YoY and by 2.8% from the previous quarter
The ROS has grown by 4.7% YoY and by 2.3% from the previous quarter
The ROIC has grown by 4% YoY and by 3% from the previous quarter
Dividends
What is ABT's dividend history
DPS
$2.24
Dividend yield
1.66%
Payout ratio
67.9%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Abbott Laboratories financials performed over time
The total assets is 117% more than the total liabilities
The current ratio has decreased by 8% YoY and by 4.8% QoQ
ABT's quick ratio is down by 3.8% year-on-year
Abbott Laboratories's debt is 63% lower than its equity
Abbott Laboratories's debt to equity has decreased by 10% YoY
ABT's equity is up by 6% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.